Susan R. Hopkins

The effect of salbutamol on performance in elite nonasthmatic athletes.

The effect of salbutamol on performance was studied in seven male nonasthmatic highly trained (VO2max > or = 60 ml.kg-1 x min-1) cyclists. Salbutamol (S = 2 puffs = 200 micrograms) or placebo (P) was administered by metered-dose inhaler, through a spacer device, 20 min prior to testing in a double-blind, randomized cross-over design. Testing sessions on a cycle ergometer included the measurement of maximal oxygen uptake (VO2max), peak power, maximal heart rate, and pulmonary function. A timed sprint to exhaustion was performed after 45 min of exercise at 70% of VO2max, and a Wingate anaerobic test was used to measure total work and peak power. There was a nonsignificant decrease in VO2max (P = 63.5 +/- 3.2; S = 62.6 +/- 3.3 ml.kg-1 x min-1). No difference was found in peak power, maximum heart rate, endurance sprint time, Wingate peak power, or total work. After an anticipated baseline increase was taken into account, the pattern of change in FEV1 over time did not differ between salbutamol and placebo. It was concluded that a therapeutic dose of aerosol salbutamol does not have an ergogenic effect in elite nonasthmatic athletes, and it is therefore recommended that inhaled salbutamol continue to be permitted in international competition for individuals with exercise induced bronchospasm.

Pulmonary transit time and diffusion limitation during heavy exercise in athletes

To investigate relationships between pulmonary transit times (PTT) and pulmonary diffusion limitation during exercise, 10 high aerobic capacity athletes (VO2max = 5.15 +/- 0.52 l.min-1) who had multiple inert gas elimination analysis evidence suggestive of diffusion disequilibrium were studied at rest and maximal exercise. Diffusing capacity for oxygen (DLO2) was calculated from the inert gas data. First pass radionuclide angiography was performed using 99mTechnecium labeled erythrocytes and whole lung PTT and pulmonary blood volume (PBV) were calculated. PTT decreased from 9.32 +/- 1.41 sec at rest, to 2.91 +/- 0.30 sec during exercise and was correlated with diffusion limitation suggested by the inert gases (r = -0.58, P < 0.05). PBV increased during exercise to over 25% of whole blood volume and correlated with DLO2 (r = 0.82, P < 0.01). These data suggest that diffusion limitation is related to shortened PTT in athletes and that maximal recruitment of PBV may defend against diffusion limitation.

Respiratory Factors Limiting Maximal Aerobic Exercise

In humans, the respiratory system has long been regarded as adequate in healthy humans exercising at sea level, although respiratory limitation of exercise performance has been recognized in some athletic mammals. In recent years, the respiratory system has attracted attention as a potential limiting factor in human performance. This brief review examines the available literature in both humans and animals in an attempt to explain the mechanisms by which energetics, muscle fatigue, mechanical limitation, respiratory drives, and gas exchange could limit exercise performance in highly trained humans. The data suggest that pulmonary constraint of performance is likely, particularly during short-term near maximal exercise.